The main aim of this study was to elucidate whether plasma protein levels of Chitinase, IDO and HO-1 could also aid as prognostic immune biomarkers for unfavorable pulmonary TB treatment outcomes. The gene discussed is HMOX1; the disease is pulmonary tuberculosis.